© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
June 22, 2021
An interview with a study author on unique associations between county infrastructures and COVID-19 fatality rates.
The device may help clinicians differentiate between past infections and co-infections during the upcoming flu season.
Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
June 21, 2021
New findings on an available 15-minute test show an approximate 81% sensitivity in detection of SARS-CoV-2.
New findings from the ASM 2021 World Microbe Forum suggest the emergency-authorized platform can capably detected the highly transmissible UK-borne variant.
June 15, 2021
Five people in 4 US states in the 20-21 influenza season contracted influenza A virus variants commonly spread among pigs, but without person-to-person spread.
June 13, 2021
Cartesian Therapeutics has created its therapy, Descartes-30, the first RNA cell therapy for acute respiratory distress syndrome (ARDS), and the company is now recruiting for a clinical trial.
June 10, 2021
Paratek’s omadacycline (Nuzyra) is granted approval for an oral-only dosing regimen in adults.
Rapid respiratory virus test results for children in an emergency department could be received too late to inform antibiotic prescribing.
June 04, 2021
The authorization change halves the required dose of the monoclonal antibody regimen, based on recent data.